Rocca, Andrea https://orcid.org/0000-0003-4613-8884
Crinò, Lucio
Braga, Luca
Salton, Francesco
Ruaro, Barbara
Confalonieri, Marco
Generali, Daniele
Confalonieri, Paola
Article History
Received: 20 December 2024
Revised: 26 June 2025
Accepted: 21 July 2025
First Online: 23 August 2025
Competing interests
: The authors declare the following competing interests: Daniele Generali declares personal fees for educational events by Novartis, Lilly, Pfizer, Daiichy-Sankyo, Roche; research funds from Astrazeneca, Novartis and LILT. Andrea Rocca has been salaried through a research fund provided by Novartis to the University of Trieste. The other authors have nothing to declare.
: During the preparation of this work the authors used ChatGPT in order to improve readability of some sentences or paragraphs. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.